What does oligospermia (low semen volume) in semen analysis indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Oligospermia, or low semen volume, in semen analysis is a significant indicator of potential male infertility issues, particularly suggesting distal male genital tract obstruction.

Key Indicators of Distal Male Genital Tract Obstruction

  • Low semen volume: Less than 1.4 mL, as indicated by the World Health Organization reference limits 1
  • Acidic semen pH: Less than 7.0, which can be associated with ejaculatory duct obstruction (EDO) or congenital bilateral absence of the vas deferens (CBAVD) 1
  • Azoospermia or severe oligospermia: Absence of sperm or very low sperm concentration, which can be due to obstructive or non-obstructive causes 1

Diagnostic Approaches

  • Transrectal ultrasonography (TRUS): Recommended for evaluating anatomic abnormalities in men with suspected EDO, characterized by acidic, azoospermic semen with low volume 1
  • Pelvic MRI: May provide more accurate measurements of ejaculatory duct and seminal vesicle dilation and can identify prostate cysts causing EDO 1
  • Post-ejaculatory urinalysis: Should be performed if ejaculate volume is less than 1 mL to check for retrograde ejaculation 1

Clinical Considerations

  • Retrograde ejaculation: Should be suspected in cases of low-volume or absent ejaculate, especially if accompanied by other symptoms like lack of emission or hypogonadism 1
  • Vasal agenesis: Men with bilateral vasal agenesis should undergo abdominal imaging to evaluate for renal abnormalities, given the association between vasal agenesis and renal anomalies 1

From the Research

Oligospermia Indications

Oligospermia, or low semen volume, in semen analysis can indicate several issues, including:

  • Disturbances of ejaculation reflex leading to partial retrograde ejaculation 2
  • Seminal glands and ducts anatomic and functional anomalies 2
  • Mutations of the CFTR gene, which can be involved in cystic fibrosis 2
  • Partial retrograde ejaculation (PRE), which can be diagnosed by searching for sperm in postejaculatory urine (PEU) 3
  • Low sperm count, including oligospermia and azoospermia, which can be prevalent in male infertile population 4

Associated Factors

Low semen volume can be associated with:

  • Higher percentage of non-motile sperms and abnormal morphology 4
  • Asthenospermia, teratospermia, and oligoasthenoteratospermia 4
  • Artifactual, structural, and functional etiologies of low-volume ejaculation 5
  • Influence of environmental factors, drugs, lifestyle, chemical products, and professional activities on male reproductive health 6

Diagnostic Considerations

Semen analysis is a crucial step in investigating male infertility, and low semen volume can be an important indicator of underlying issues 5, 6. The World Health Organization (WHO) provides guidelines for semen analysis, including parameters for physical and biochemical evaluation of semen, sperm characteristics, and other seminal parameters 6. A comprehensive algorithm for evaluating, diagnosing, and treating low semen volume in infertile men can help identify the underlying causes and develop effective treatment plans 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Why and how to assess hypospermia?].

Gynecologie, obstetrique & fertilite, 2008

Research

Steps in the investigation and management of low semen volume in the infertile man.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2009

Research

Semen analysis in laboratory practice: an overview of routine tests.

Journal of clinical laboratory analysis, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.